Intuitive Surgical Recalls Put Da Vinci Reliability And Valuation In Focus

• Intuitive Surgical, ticker NasdaqGS:ISRG, is facing multiple ongoing voluntary product recalls tied to its da Vinci surgical systems and associated instruments.
• In May 2026, the US FDA announced a Class I recall of SureForm 30 Gray Reloads due to incomplete staple lines, affecting products distributed in the US and internationally.
• Additional recalls involve certain da Vinci X and Xi system sub components because of the risk of screws breaking within the arm sub assembly.
• These actions raise questions around clinical use, safety perceptions, and future regulatory oversight for the company’s core robotic platforms.

For investors watching NasdaqGS:ISRG, these recalls arrive after a period of weaker share performance, with the stock down 9.5% over the past 30 days and down 22.3% year to date. The current share price of $436.64 also sits below its level from one year ago, with the stock down 20.6% over that period, even though the 3 year and 5 year returns are 42.2% and 56.7% respectively.

The recalls focus attention squarely on product reliability and regulatory relationships at a time when Intuitive Surgical’s da Vinci platforms remain central to its business. Investors may watch closely for any updates on the scope and resolution of the recalls, along with how hospitals and surgeons respond in their day to day use of the affected systems.

Stay updated on the most important news stories for Intuitive Surgical by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Intuitive Surgical.

📰 Beyond the headline: 0 risks and 3 things going right for Intuitive Surgical that every investor should see.

Investor Checklist

Quick Assessment

• ✅ Price vs Analyst Target: At US$436.64, the stock trades about 24% below the US$572.68 analyst price target midpoint.
• ⚖️ Simply Wall St Valuation: Shares are described as trading close to estimated fair value, so there is no strong valuation skew in either direction.
• ❌ Recent Momentum: The share price is down 9.5% over the past 30 days, showing weak short term momentum.

There is only one way to know the right time to buy, sell or hold Intuitive Surgical: Head to Simply Wall St's company report for the latest analysis of Intuitive Surgical's Fair Value.

Key Considerations

• 📊 Ongoing product recalls put extra focus on how much of Intuitive Surgical's investment case depends on confidence in the da Vinci ecosystem.
• 📊 Watch for updates on recall resolution, procedure volumes, and any commentary from hospitals or surgeons about system usage.
• ⚠️ The key risk is that further regulatory scrutiny or extended recalls could affect perceptions of product reliability and adoption decisions.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Intuitive Surgical analysis. Alternatively, you can check out the community page for Intuitive Surgical to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com